NBPE Announces November 2023 NAV Estimate
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil settles up 2% after Trump rejects return to Iran ceasefire deal terms
- Could SpaceX's orbital compute avoid the political headwinds facing data centers?
- Could Meta's teen settlement be less painful than feared? Citi weighs in
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- First Financial to acquire Hickory Point Bank in $111.3M deal
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- Revolution Medicines prices RASONQUE at $39,800 per month
These 6 stocks are new Top Picks at Jefferies
December 20, 2023 3:51 PM ESTJefferies' Franchise Picks represent their analysts most confident, Buy-rated stocks within the research companys US Research portfolio. These top selections are backed by thorough analysis, distinct factors, and favorable valuations indicating potential for growth.
This month, Jefferies added 6 new ideas to the list.
argenx SE
argenx (NASDAQ: ARGX) was added to the list as Jefferies analysts consider the biotechnology companys s lead asset, Vyvgart, to be a best-in-class drug owing to its potent IgG drops, clean safety profile without dose-limiting albumin drops or effector-related adverse events, and convenient... More
